Parkinsonism & Related Disorders
Volume 18, Issue 2 , Pages 130-135 , February 2012

Loss of ability to work and ability to live independently in Parkinson’s disease

  • Barbara Jasinska-Myga

      Affiliations

    • Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
    • Department of Neurology, Medical University of Silesia, Katowice, Poland
    • ,
  • Michael G. Heckman

      Affiliations

    • Biostatistics Unit, Mayo Clinic, Jacksonville, FL, USA
    • ,
  • Christian Wider

      Affiliations

    • Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
    • Department of Clinical Neurosciences, CHUV, Lausanne, Switzerland
    • ,
  • John D. Putzke

      Affiliations

    • Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
    • ,
  • Zbigniew K. Wszolek

      Affiliations

    • Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
    • ,
  • Ryan J. Uitti

      Affiliations

    • Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 904 953 7229; fax: +1 904 953 0757.

Received 28 February 2011 ,Revised 22 August 2011 ,Accepted 26 August 2011.

References 

  1. Martikainen KK, Luukkaala TH, Marttila RJ. Parkinson’s disease and working capacity. Mov Disord. 2006;21(12):2187–2191
  2. Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky RL. The health burdens of Parkinson’s disease. Mov Disord. 1998;13(3):406–413
  3. Schrag A, Ben-Shlomo Y, Brown R, Marsden CD, Quinn N. Young-onset Parkinson’s disease revisited–clinical features, natural history, and mortality. Mov Disord. 1998;13(6):885–894
  4. Clarke CE, Zobkiw RM, Gullaksen E. Quality of life and care in Parkinson’s disease. Br J Clin Pract. 1995;49(6):288–293
  5. Schrag A, Banks P. Time of loss of employment in Parkinson’s disease. Mov Disord. 2006;21(11):1839–1843
  6. Banks P, Lawrence M. The Disability Discrimination Act, a necessary, but not sufficient safeguard for people with progressive conditions in the workplace? The experiences of younger people with Parkinson’s disease. Disabil Rehabil. 2006;28(1):13–24
  7. Post B, Merkus MP, de Haan RJ, Speelman JD. Prognostic factors for the progression of Parkinson’s disease: a systematic review. Mov Disord. 2007;22(13):1839–1851quiz 988
  8. Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology. 2008;70(23):2241–2247
  9. Shulman LM, Gruber-Baldini AL, Anderson KE, Vaughan CG, Reich SG, Fishman PS, et al. The evolution of disability in Parkinson disease. Mov Disord. 2008;23(6):790–796
  10. de Rijk MC, Rocca WA, Anderson DW, Melcon MO, Breteler MM, Maraganore DM. A population perspective on diagnostic criteria for Parkinson’s disease. Neurology. 1997;48(5):1277–1281
  11. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson’s disease. Adv Neurol. 1990;53:245–249
  12. Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ. Gender and the Parkinson’s disease phenotype. J Neurol. 2005;252(10):1201–1205
  13. Uitti RJ, Baba Y, Wszolek ZK, Putzke DJ. Defining the Parkinson’s disease phenotype: initial symptoms and baseline characteristics in a clinical cohort. Parkinsonism Relat Disord. 2005;11(3):139–145
  14. Rubenstein LM, DeLeo A, Chrischilles EA. Economic and health-related quality of life considerations of new therapies in Parkinson’s disease. Pharmacoeconomics. 2001;19(7):729–752
  15. Dowding CH, Shenton CL, Salek SS. A review of the health-related quality of life and economic impact of Parkinson’s disease. Drugs Aging. 2006;23(9):693–721
  16. Huse DM, Schulman K, Orsini L, Castelli-Haley J, Kennedy S, Lenhart G. Burden of illness in Parkinson’s disease. Mov Disord. 2005;20(11):1449–1454
  17. Whetten-Goldstein K, Sloan F, Kulas E, Cutson T, Schenkman M. The burden of Parkinson’s disease on society, family, and the individual. J Am Geriatr Soc. 1997;45(7):844–849
  18. Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson’s disease (2001): treatment guidelines. Neurology. 2001;56(11 Suppl. 5):S1–S88
  19. Calne SM, Lidstone SC, Kumar A. Psychosocial issues in young-onset Parkinson’s disease: current research and challenges. Parkinsonism Relat Disord. 2008;14(2):143–150
  20. Poewe W, Mahlknecht P. The clinical progression of Parkinson’s disease. Parkinsonism Relat Disord. 2009;15(Suppl. 4):S28–S32

☆ The review of this paper was entirely handled by an Associate Editor, R.L. Rodnitzky.

PII: S1353-8020(11)00276-8

doi: 10.1016/j.parkreldis.2011.08.022

Parkinsonism & Related Disorders
Volume 18, Issue 2 , Pages 130-135 , February 2012

Article Tools

* Image Usage & Resolution